Institutional investors purchased a net $482.9 thousand shares of CGIX during the quarter ended September 2016. This may signal that the smart money is gaining interest in this company as the 12.25% of shares outstanding that institutional investors hold is actually below the Medical/Nursing Services industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PERKINS CAPITAL MANAGEMENT, INC. Bought 283.4 Thousand shares of Cancer Genetics Inc
FRIGATE VENTURES LP Bought 271.7 Thousand shares of Cancer Genetics Inc
RENAISSANCE TECHNOLOGIES LLC Bought 75.5 Thousand shares of Cancer Genetics Inc